Related Experiment Videos
Monoclonal antibodies in urology
The Journal of Urology
|September 1, 1983
Summary
Hybridoma technology enables monoclonal antibody production for diverse applications. These antibodies are crucial in diagnostics, research, and treating diseases like cancer, with a focus on urological conditions.
Area of Science:
- Biotechnology
- Immunology
- Medical Diagnostics
Background:
- Hybridoma technology allows for the production of specific antibodies.
- Monoclonal antibodies target single determinants, offering high specificity.
- Advances in hybridoma technology have revolutionized antibody production.
Purpose of the Study:
- To review the history and methods of hybridoma technology.
- To examine the applications of monoclonal antibodies in various scientific fields.
- To highlight the role of monoclonal antibodies in diagnosing and treating urological diseases.
Main Methods:
- Review of historical development of hybridoma technology.
- Description of monoclonal antibody production techniques.
- Analysis of current research and clinical applications.
Main Results:
- Monoclonal antibodies are vital tools in diagnostics and research.
- Applications span tissue typing, histochemistry, and developmental biology.
- Significant progress has been made in using monoclonal antibodies for cancer and urological disease management.
Conclusions:
- Hybridoma technology has transformed antibody production.
- Monoclonal antibodies have broad applications in medicine and biology.
- Further research on monoclonal antibodies holds promise for urological disease treatment.